Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis
- PMID: 956814
- DOI: 10.1007/BF01249445
Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis
Abstract
It could be shown that the post mortem analysis of biogenic amines, precursors and metabolites in the human brain are influenced by various parameters. 1. The patient's medical history; long term observations of the course of the disease; age; sex. 2. Terminal illness; duration of terminal illness. 3. Previous treatment with drugs; last drugs. 4. Time interval between last drug treatment and death; time of day and date of last drug consumption. 5. Rapidity of death; time of death; duration of coma. 6. Changes occurring in tissues before death; patients' constitution during terminal illness. 7. Changes in concentration of the biogenic amines, precursors, and metabolites depending on the patient's age. 8. Time between death and necropsy. 9 Dissection of specimen. 10. Period of storage; temperature of storage. 11. Chronbiological rhythm of substances. 12. Methods of assayL 13. Homogeneity of all mentioned parameters in the control group and patient's group. For the first time it could be demonstrated that the time course of nigrostriatal degeneration, independent of the age of the parkinsonian at the beginning of the illness, is linear for the last stage and the denervation progressively increases as the duration of illness progresses.
Similar articles
-
Seasonal and circadian monoamine variations in human brains examined post mortem.Acta Psychiatr Scand Suppl. 1980;280:75-85. Acta Psychiatr Scand Suppl. 1980. PMID: 6157305 Review. No abstract available.
-
Regional distribution of monoamines and their metabolites in the human brain.J Neurochem. 1978 Apr;30(4):841-8. doi: 10.1111/j.1471-4159.1978.tb10792.x. J Neurochem. 1978. PMID: 650225 No abstract available.
-
[Age and changes in the levels of biogenic amines in the brains of rats].Fiziol Zh SSSR Im I M Sechenova. 1977 Mar;63(3):353-8. Fiziol Zh SSSR Im I M Sechenova. 1977. PMID: 863030 Russian.
-
Corticoliberin, somatocrinin and amine contents in normal and parkinsonian human hypothalamus.Neurosci Lett. 1985 May 14;56(2):217-22. doi: 10.1016/0304-3940(85)90132-6. Neurosci Lett. 1985. PMID: 2409485
-
Amine accumulation in Parkinson's disease and other disorders.Neurosci Biobehav Rev. 1987 Spring;11(1):97-105. doi: 10.1016/s0149-7634(87)80004-0. Neurosci Biobehav Rev. 1987. PMID: 2952907 Review.
Cited by
-
Non-invasive vagus nerve stimulation improves clinical and molecular biomarkers of Parkinson's disease in patients with freezing of gait.NPJ Parkinsons Dis. 2021 May 27;7(1):46. doi: 10.1038/s41531-021-00190-x. NPJ Parkinsons Dis. 2021. Retraction in: NPJ Parkinsons Dis. 2022 Nov 3;8(1):148. doi: 10.1038/s41531-022-00424-6 PMID: 34045464 Free PMC article. Retracted.
-
Axon degeneration in Parkinson's disease.Exp Neurol. 2013 Aug;246:72-83. doi: 10.1016/j.expneurol.2012.01.011. Epub 2012 Jan 18. Exp Neurol. 2013. PMID: 22285449 Free PMC article. Review.
-
Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons.Proc Natl Acad Sci U S A. 2012 Feb 28;109(9):3213-9. doi: 10.1073/pnas.1200575109. Epub 2012 Feb 6. Proc Natl Acad Sci U S A. 2012. PMID: 22315428 Free PMC article.
-
Transplantation into the human brain: present status and future possibilities.J Neurol Neurosurg Psychiatry. 1989 Jun;Suppl(Suppl):39-54. doi: 10.1136/jnnp.52.suppl.39. J Neurol Neurosurg Psychiatry. 1989. PMID: 2666578 Free PMC article. Review. No abstract available.
-
Brain monoamines in human hepatic encephalopathy.Acta Neuropathol. 1978 Aug 7;43(1-2):63-8. doi: 10.1007/BF00684999. Acta Neuropathol. 1978. PMID: 676688 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
